RAMM Pharma Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Equivalents	0.99	0.8	0.81	5.12	9.77	17.16
Cash & Short-Term Investments	0.99	0.8	0.81	5.12	9.77	17.16
Cash Growth	105.10%	-1.25%	-84.09%	-47.65%	-43.03%	-38.74%
Accounts Receivable	0.47	0.45	0.78	0.62	0.92	1.17
Other Receivables	0	0.43	0.86	1.26	1.83	2.78
Receivables	0.47	0.88	1.64	1.88	2.74	3.95
Inventory	0.88	0.93	2.54	3.14	4.02	3.05
Prepaid Expenses	-	0.03	0.26	0.22	0.08	0.06
Other Current Assets	-	0	0.1	0.24	0.03	0.06
Total Current Assets	2.34	2.64	5.36	10.59	16.65	24.28
Property, Plant & Equipment	6.11	6.63	11.2	19.05	19.71	19.34
Goodwill	-	-	-	-	-	12.85
Other Intangible Assets	0	0	0.19	0.49	0.8	1.47
Other Long-Term Assets	-	-	-	2.17	2.08	1.86
Total Assets	8.45	9.27	16.75	32.3	39.24	59.8
Accounts Payable	3.5	0.38	0.64	1.21	1.11	1.93
Accrued Expenses	-	0.28	0.36	0.33	0.56	0.48
Current Portion of Leases	0.06	0.07	0.1	0.23	0.23	0.03
Current Income Taxes Payable	-	-	0.01	0.01	0.01	0
Other Current Liabilities	-	2.83	1.92	0.87	1.3	0.87
Total Current Liabilities	3.56	3.56	3.03	2.66	3.2	3.32
Long-Term Leases	-	0.01	0.08	0.18	0.45	0
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.09
Total Liabilities	3.56	3.57	3.11	2.84	3.66	3.41
Common Stock	60.99	60.99	60.99	60.99	62.52	63.06
Additional Paid-In Capital	7.17	7.17	6.87	3.05	1.36	1.36
Retained Earnings	-75.58	-74.82	-65.91	-49.45	-43.09	-22.44
Comprehensive Income & Other	12.31	12.36	11.69	14.88	14.79	14.42
Shareholders' Equity	4.89	5.7	13.63	29.46	35.59	56.39
Total Liabilities & Equity	8.45	9.27	16.75	32.3	39.24	59.8
Total Debt	0.06	0.08	0.19	0.41	0.68	0.03
Net Cash (Debt)	0.92	0.72	0.63	4.71	9.09	17.12
Net Cash Growth	226.82%	15.62%	-86.72%	-48.16%	-46.92%	-38.64%
Net Cash Per Share	0.01	0.01	0.01	0.04	0.07	0.16
Filing Date Shares Outstanding	119.39	119.39	119.39	119.39	122.4	123.45
Total Common Shares Outstanding	119.39	119.39	119.39	119.39	122.4	123.45
Working Capital	-1.22	-0.92	2.33	7.93	13.45	20.97
Book Value Per Share	0.04	0.05	0.11	0.25	0.29	0.46
Tangible Book Value	4.89	5.69	13.45	28.97	34.78	42.07
Tangible Book Value Per Share	0.04	0.05	0.11	0.24	0.28	0.34
Land	-	2.48	3.7	4.58	4.42	4.18
Machinery	-	5.5	5.66	6.06	5.82	4.76
Construction In Progress	-	3.3	6.32	12.05	11.96	12.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.